MapLight Therapeutics, Inc.
MPLT
$16.14
$0.140.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.82M | 3.76M | 3.07M | 3.07M | 4.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.66M | 23.54M | 21.84M | 21.84M | 19.99M |
| Operating Income | -30.66M | -23.54M | -21.84M | -21.84M | -19.99M |
| Income Before Tax | -29.85M | -22.34M | -20.12M | -20.12M | -18.40M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.85M | -22.34M | -20.12M | -20.12M | -18.40M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.85M | -22.34M | -20.12M | -20.12M | -18.40M |
| EBIT | -30.66M | -23.54M | -21.84M | -21.84M | -19.99M |
| EBITDA | -30.53M | -23.38M | -21.64M | -21.64M | -19.81M |
| EPS Basic | -39.11 | -29.33 | -26.51 | -26.51 | -24.31 |
| Normalized Basic EPS | -24.61 | -18.33 | -16.39 | -16.39 | -15.54 |
| EPS Diluted | -39.11 | -29.33 | -26.51 | -26.51 | -24.31 |
| Normalized Diluted EPS | -24.61 | -18.33 | -16.39 | -16.39 | -15.54 |
| Average Basic Shares Outstanding | 763.10K | 761.60K | 759.10K | 759.10K | 757.00K |
| Average Diluted Shares Outstanding | 763.10K | 761.60K | 759.10K | 759.10K | 757.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |